Choosing a reputable healthcare professional, reviewing your medical history, following dose instructions, drinking enough water, and watching for any side effects before receiving whitening injections are important
Both medications target dual GLP-1/GIP receptors, but only Tirzepatide has FDA approval and is available by prescriptionSurvodutide remains restricted to clinical trial participants
Clinical studies have demonstrated that semaglutide, when used as an adjunct to diet and exercise, can significantly reduce HbA1c (a measure of long-term blood sugar control) and fasting plasma glucose levels
Smaller, incremental dose adjustments could enhance treatment outcomes or reduce non-compliance or early termination of a GLP-1 because it could help with dose tolerability
Human evidence - Phase 3 TRIUMPH-1 (Eli Lilly, May 21, 2026) 2,339 adults with obesity or overweight without diabetes
Benefits Include: Rich in antioxidants